Natural Killer cells role in embryonic implantion
Camila Langer Marciano, Thalia de Sousa da Silva, Murilo Andrade Nantes, Ana Gabriela Souza Gouvea, Cynthia Hernandes Costa, Renata Matuo
Abstract
Objective: This work aimed to elucidate the natural killer cells role during embryonic implantation process and its possible relation in abortion. Methods: A bibliographical revision was made based on scientific articles from electronic databases as Google academic, Scielo and PUBMED, and books, published in Portuguese and English, from 2003 to 2019. Results: During female reproductive cycle, NK cells act in ovulation and allows the discernment of changing from endometrium in decomposition (menstruation) to decidualization in pregnancy. In addition, NK may also influence implantation and presents a correlation with recurrent abortion. Conclusion: NK’s performance in female deciduous is still controversial, so it is necessary more studies to better understand this subject.
Keywords
References
1. Corrêa MCD, Costa C. Reprodução humana [Internet]. Rio de Janeiro: Projeto Ghente; 2008 [cited 2016 Nov 10]. Available from: http://www.ghente.org/
2. Machado MH. Reprodução humana assistida: aspectos éticos e jurídicos. Curitiba: Juruá; 2012. 156 p.
3. Organização Mundial da Saúde. Infertility definitions and terminology. Genebra: OMS; 2016.
4. Michelon T, Silveira JG, Graudenz M, Neumann J. Pregnancy immunology. Revista da AMRIGS. 2006;50(2):145-51.
5. Abbas AK, Lichtman AH. Imunologia básica: funções e distúrbios do sistema imunológico. 3. ed. Rio de Janeiro: Elsevier; 2009.
6. Moffett A, Shreeve N. First do no harm: Uterine natural killer (NK) cells in assisted reproduction. Hum Reprod. 2015;30(7):1519-25. http://dx.doi.org/10.1093/humrep/dev098. PMid:25954039.
7. Vacca P, Chiossone L, Mingari MC, Moreta L. Heterogeneity of NK cells and other innate lymphoid cells in human and murine decidua. Front Immunol. 2019;10(170):1-8.
8. Nuñez AP, Wolff P, Salgado RM. O papel da interleucina 11 durante a implantação embrionária. ACIS. 2013;1(2):1-28.
9. Jobim M, Jobim LF. Natural killer cells and immune surveillance. J Pediatr (Rio J). 2008;84(Suppl 4):S58-67. http://dx.doi.org/10.1590/S0021-75572008000500009. PMid:18830515.
10. Costa CH. Variações alélicas e combinações KIR2DL4 e HLA-G em casais submetidos a tratamento de reprodução assistida [tese de doutorado]. Paraná (BR): Universidade Federal do Paraná; 2015. 155 p.
11. Borges E Jr, Farah LMS, Cortezzi SS. Reprodução humana assistida. São Paulo: Atheneu, 2011. 352p.
12. Moore KL, Persaud TVN. Embriologia básica. 7. ed. Rio de Janeiro: Elsevier, 2008.
13. Hoffman BL, Schorge JO, Halvorson LM, Bradshaw KD, Cunningham FG. Ginecologia de Williams. São Paulo: Amgh Editora, 2012. 1402 p.
14. Jena MK, Nayak N, Chen K, Nayak NR. Role of macrophages in pregnancy and related complications. Arch Immunol Ther Exp (Warsz). 2019;67(5):295-309. http://dx.doi.org/10.1007/s00005-019-00552-7. PMid:31286151.
15. Gelmini GF, Costa CH, Bicalho MG, Roxo VMS, Schuffner A. Does exist HLA-E influence on human reproduction? Sociedade Brasileira de Reprodução Assistida SBRA. 2010;14(2):50-54.
16. Lima C, Auler JR. Injúria endometrial: mecanismos, tratamentos e eficácia. 2013. [cited 2016 Nov 10], Available from: http://www.pronascer.com.br/images/news_pn/Editorial%20Clinica%20Pro%20Nascer%20-%20Medicina%20Reprodutiva%20-%20Ed_02-01. pdf
17. Dias JA Jr. Evaluation of the percentage of natural killer cells and autoantibodies in the peripheral blood of patients with pelvic endometriosis [dissertation]. São Paulo (BR): Universidade de São Paulo; 2010. 108 p.
18. Seeley RR, Stephens TD, Tate P. Anatomia & Fisiologia. 6. ed. Portugal: Lusociencia. 2003. 1118 p.
19. Marino FFLO. Evaluation of the levels of interleukines 12 and 18 in blood and peritoneal fluid of patients with pelvic endometriosis [dissertation]. São Paulo (BR): Universidade de São Paulo; 2006. 94 p.
20. Sarafana S, Coelho R, Neves A, Costa Trindade J. Gestational immunology. Acta Med Port. 2007;20(4):355-8. PMid:18198080.
21. Ahmadi M, Ghaebi M, Abdolmohammadi-Vahid S, Abbaspour-Aghdam S, Hamdi K, Abdollahi-Fard S, et al. NK cell frequency and cytotoxicity in correlation to pregnancy out come and response to IVIG therapy among women with recurrent pregnancy loss. J Cell Physiol. 2018;234(6):9428-37. http://dx.doi.org/10.1002/jcp.27627. PMid:30317625.
22. Moffett A, Regan L, Braude P. Natural killer cells, miscarriage, and infertility. BMJ. 2004;329(7477):329. http://dx.doi.org/10.1136/bmj.329.7477.1283. PMid:15564263.
23. Parham P. NK Cells and trophoblasts: Partners in Pregnancy. J Exp Med. 2004;200(8):951-5. http://dx.doi.org/10.1084/jem.20041783. PMid:15492121.
24. Blois SM, Freitag N, Tirado-González I, Cheng SB, Heimesaat MM, Bereswill S, et al. NK cell-derived IL-10 is critical for DC-NK cell dialogue at the maternal-fetal interface. Sci Rep. 2017;2189(1):1-9. http://dx.doi.org/10.1038/s41598-017-02333-8. PMid:28526846.
25. Fu B, Zhou Y, Ni X, Tong X, Ding Z, Sun R, et al. Natural Killer cells promote fetal development through the secretion of growthpromoting factors. Immunity. 2017;47(6):1100-13. http://dx.doi.org/10.1016/j.immuni.2017.11.018. PMid:29262349.
26. Caetano MR, Couto E, Passini R Jr, Simoni RZ, Barini R. Gestational prognostic factors in women with recurrent spontaneous abortion. Sao Paulo Med J. 2006;124(4):181-5. http://dx.doi.org/10.1590/S1516-31802006000400002. PMid:17086297.
27. Mattar R, Traína E, Daher S. Limits in the immunological and genetical investigation of recurrent abortion. Rev Bras Ginecol Obstet. 2015; 37(3):101-4.
28. Allahbadia GN. Intralipid infusion is the current favorite of gynecologists for immunotherapy. J Obstet Gynaecol India. 2015;65(4):213-7. http://dx.doi.org/10.1007/s13224-015-0732-7. PMid:26243984.
29. Lédée N, Vasseur C, Petitbarat M, Chevrier L, Vezmar K, Dray G, et al. Intralipid may represent a new hope for patients with reproductive failures and simultaneously an over-immune endometrial activation. J Reprod Immunol. 2018;130:18-22. http://dx.doi.org/10.1016/j.jri.2018.09.050. PMid:30286362.
30. Ehrlich R, Hull ML, Walkley J, Sacks G. Intralipid immunotherapy for repeated IVF failure. Fertility & Reproduction. 2019;1(4):154-60. http://dx.doi.org/10.1142/S2661318219500178.
31. Martini AE, Jasulaitis S, Fogg LF, Uhler ML, Hirshfeld-Cytron JE. Evaluating the utility of Intralipid infusion to improve live birth rates in patients with recurrent pregnancy loss or recurrent implantation failure. J Hum Reprod Sci. 2018;11(3):261-68.
Submitted date:
07/31/2019
Accepted date:
07/08/2020
Facebook
Google+
Twitter
LinkedIn
Mendeley
StumbleUpon
CiteULike
Reddit
Email